Garrett Vygantas, M.D.

Garrett Vygantas, M.D., is a prominent figure in the healthcare and life sciences investment landscape. He is the Founder and Managing Partner of Riverine Ventures, a venture capital firm dedicated to life science and healthcare investments.24

Professional Background

Dr. Vygantas brings over 20 years of industry, investment, and entrepreneurial experience to his role.1 His expertise spans across biopharma, life sciences, healthcare, medtech, and digital health investing and operations.2

Education and Training

Garrett Vygantas holds an MD/MBA degree from Georgetown University and completed his residency at the University of Pennsylvania.2 He also has a BS in biochemistry from Boston College.3

Investment Experience

Throughout his career, Dr. Vygantas has held several notable positions:

• Founder & Managing Partner at Riverine Ventures2
• Managing Director at OSF Ventures5
• Partner at Jump Capital3
• Entrepreneur-In-Residence and Director at Burrill Venture Group3

Board Memberships and Advisory Roles

Dr. Vygantas serves as a board member or advisor to numerous life sciences companies, including:

• CellFE (investor)6
• AEye Health
• ArtiSight
• Corsair Pharma
• Eliksa Therapeutics
• Endotronix
• Exo Imaging
• HealthBridge12

Entrepreneurial Ventures

In addition to his investment activities, Dr. Vygantas has founded or co-founded several companies:

• Founding CEO of NewBridge Pharmaceuticals
• Founder of Ceratotech
• Co-founder of Mitre Medical3

Other Contributions

Garrett Vygantas is a Kauffman Fellow and Mentor at the Center for Venture Education.2 He is also a frequent lecturer at UCSF's Center for BioEntrepreneurship and has advised in the formation of numerous biotech startups.3

Garrett Vygantas, M.D., with his extensive experience and expertise in healthcare and life sciences investing, plays a significant role in shaping the future of precision medicine and innovative healthcare solutions.